Novartis AG
HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS
Last updated:
Abstract:
The present application relates to highly concentrated antibody and protein formulations with, reduced viscosity that are stable, relatively isotonic and are of low turbidity. The formulations are particularly suitable for subcutaneous administration. The application further describes articles of manufacture containing such formulations and method for using them to treat disorders treatable by the formulated antibody or protein.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2019
Issue date:
28 Nov 2019